NCT03936751View on ClinicalTrials.gov

Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY.

PHASE4TerminatedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

July 31, 2022

Study Completion Date

December 31, 2022

Conditions
Obstructive Sleep ApneaPulmonary Edema Cardiac Cause
Interventions
DEVICE

CPAP

This is the standard treatment for OSA.

DEVICE

Nasal Strips

Nasal strips were commercially available in the market for supposing treat snoring and sleep apnea but no proof that this is true. Our group previously validated nasal strips as an interesting placebo.

Trial Locations (4)

Unknown

PROCAPE - University of Pernambuco, Recife

Hospital Samaritano, São Paulo

Hospital Dante Pazzanese, São Paulo

05049000

Heart Institute (InCor), São Paulo

Sponsors

Collaborators (1)

Philips Respironics
All Listed Sponsors
collaborator

Philips Respironics

INDUSTRY

collaborator

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

collaborator

Conselho Nacional de Desenvolvimento Científico e Tecnológico

OTHER_GOV

lead

University of Sao Paulo

OTHER

NCT03936751 - Obstructive Sleep Apnea Treatment on Cardiovascular Events in Patients With Acute Cardiogenic Pulmonary Edema: CPAP-CARE STUDY. | Biotech Hunter | Biotech Hunter